Previous studies have also shown elevated muscle levels of numerous cytokines associated with type 1 inflammation, including CCL5, CXCL9, CXCL10, CXCL11, IFNG, and TNF in IBM patients compared to various myositis and non-myositis controls[6, 8–11]. This evidence concerns the gene CXCL9 and inclusion body myositis.